Getting a Super Patent

click to enlarge

Imagine you are counsel representing a patent owner in an infringement case.  Suppose you can say to the judge and jury:

Ladies and gentlemen, you have heard my learned opponent invite you to consider whether perhaps this patent should never have been granted because of prior art that was overlooked.  But you might be interested to know that during the time that this patent application was pending, prior art searching was carried out by not one, not two, not three, not four, but five patent offices.  The Examiners in these five patent offices were fluent in the Chinese, English, French, German, Japanese and Korean languages.  Before the claims were found to be patentable, these Examiners shared with each other the prior art that they found.  The Examiners from these five patent offices shared their thoughts as to whether the claims were patentable in view of the prior art that was found.  Only after all of these things took place did the patent office decide to grant a patent.  And this is the patent before you now.

I’d call such a patent a Super Patent.  Yes under US law any patent is to be presumed valid, but I suggest such a patent would enjoy a much greater presumption of validity.  Would you like to learn how to get such a Super Patent? Continue reading “Getting a Super Patent”

Pharma/biotech European patent claiming CLE free of charge!

I am delighted to be able to invite people to attend a pharma/biotech continuing legal education program.  This remarkable program lets you hear from an important person in the biotechnology part of the European Patent Office, Dr. Klaus-Peter Döpfer, and a very experienced patent practitioner in the pharma/biotech field, Ms. Sandra Pohlman.  They will talk about smart ways to draft patent applications with EPO subject matter eligibility in mind.   Continue reading “Pharma/biotech European patent claiming CLE free of charge!”

Private in-house PCT and DAS Training

In a recent blog post I listed the remarkable number of opportunities in the next few months for public PCT and DAS training programs.  What readers might not know about is that in addition to the many PCT and DAS training programs that are provided to the general public, many PCT and DAS training programs take place privately at law firms and corporations, as I will describe. Continue reading “Private in-house PCT and DAS Training”

A smart thing that USPTO customers should do now

(Please also see a followup blog article here.)

Those who make use of Private PAIR and EFS-Web are accustomed to USPTO’s very clunky way of accomplishing two-factor authentication, namely the poorly designed Entrust Java Applet (EJA).  USPTO has now formally announced (see excerpt at right from a slide in a USPTO webinar yesterday) that it will replace EJA with a much more user-friendly approach.  The goals of today’s blog article are:

  • describe the new system, and
  • explain what you can do right now to be ready for it well in advance.

Continue reading “A smart thing that USPTO customers should do now”